108.33
1.25%
1.34
アフターアワーズ:
108.33
前日終値:
$106.99
開ける:
$108.99
24時間の取引高:
453.41K
Relative Volume:
0.93
時価総額:
$3.39B
収益:
$560.03M
当期純損益:
$-150.66M
株価収益率:
-22.29
EPS:
-4.86
ネットキャッシュフロー:
$-87.43M
1週間 パフォーマンス:
+10.88%
1か月 パフォーマンス:
+18.46%
6か月 パフォーマンス:
+7.06%
1年 パフォーマンス:
-2.01%
Irhythm Technologies Inc Stock (IRTC) Company Profile
名前
Irhythm Technologies Inc
セクター
電話
415-632-5700
住所
699 8TH STREET, San Francisco, CA
IRTC を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
108.33 | 3.39B | 560.03M | -150.66M | -87.43M | -4.86 |
ABT
Abbott Laboratories
|
113.48 | 196.83B | 41.22B | 5.77B | 6.49B | 3.29 |
SYK
Stryker Corp
|
383.42 | 146.17B | 21.97B | 3.59B | 3.21B | 9.33 |
BSX
Boston Scientific Corp
|
98.66 | 145.41B | 15.91B | 1.79B | 1.89B | 1.21 |
MDT
Medtronic Plc
|
88.08 | 112.94B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
69.78 | 41.16B | 6.60B | 4.16B | 490.10M | 6.93 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-03 | 再開されました | Wells Fargo | Equal Weight |
2024-10-04 | 開始されました | Goldman | Neutral |
2024-06-20 | アップグレード | Wolfe Research | Peer Perform → Outperform |
2023-12-11 | アップグレード | Citigroup | Neutral → Buy |
2023-07-19 | 開始されました | Robert W. Baird | Outperform |
2023-02-07 | 開始されました | Wells Fargo | Overweight |
2022-11-07 | アップグレード | Wolfe Research | Underperform → Peer Perform |
2022-06-09 | ダウングレード | Citigroup | Buy → Neutral |
2022-04-06 | 開始されました | Wolfe Research | Underperform |
2022-02-24 | アップグレード | Needham | Hold → Buy |
2022-01-18 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2022-01-12 | アップグレード | BTIG Research | Neutral → Buy |
2022-01-11 | アップグレード | Oppenheimer | Perform → Outperform |
2021-12-21 | 再開されました | Canaccord Genuity | Buy |
2021-12-17 | アップグレード | JP Morgan | Neutral → Overweight |
2021-12-15 | アップグレード | Citigroup | Neutral → Buy |
2021-06-02 | ダウングレード | Citigroup | Buy → Neutral |
2021-04-13 | ダウングレード | BTIG Research | Buy → Neutral |
2021-04-12 | ダウングレード | JP Morgan | Overweight → Neutral |
2021-02-26 | ダウングレード | Colliers Securities | Buy → Neutral |
2021-01-29 | 繰り返されました | Needham | Hold |
2020-11-17 | ダウングレード | Oppenheimer | Outperform → Perform |
2020-09-11 | 開始されました | Needham | Hold |
2020-09-02 | 開始されました | Robert W. Baird | Neutral |
2020-08-07 | アップグレード | Colliers Securities | Neutral → Buy |
2020-08-05 | アップグレード | Oppenheimer | Perform → Outperform |
2020-03-05 | 開始されました | Citigroup | Buy |
2020-02-06 | 開始されました | BTIG Research | Buy |
2020-01-10 | 開始されました | William Blair | Outperform |
2020-01-08 | 開始されました | SunTrust | Buy |
2019-10-22 | 開始されました | Oppenheimer | Perform |
2019-02-20 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
2018-09-13 | 繰り返されました | Canaccord Genuity | Buy |
2018-09-06 | 開始されました | Chardan Capital Markets | Buy |
2018-08-02 | アップグレード | Dougherty & Company | Sell → Neutral |
2018-07-16 | ダウングレード | Dougherty & Company | Neutral → Sell |
2017-12-01 | 開始されました | Dougherty & Company | Neutral |
すべてを表示
Irhythm Technologies Inc (IRTC) 最新ニュース
iRhythm price target raised to $125 from $112 at Needham - Yahoo Finance
What You Can Learn From iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S - Simply Wall St
Long Term Trading Analysis for (IRTC) - Stock Traders Daily
2025-01-14 | Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Shareholders to Inquire about Securities Investigation | NDAQ:IRTC | Press Release - Stockhouse Publishing
iRhythm Technologies Reports Strong Growth and Innovation - Yahoo Finance
Needham & Company LLC Issues Positive Forecast for iRhythm Technologies (NASDAQ:IRTC) Stock Price - Defense World
iRhythm Technologies, Inc. (NASDAQ:IRTC) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Analysts Set iRhythm Technologies, Inc. (NASDAQ:IRTC) Price Target at $108.45 - MarketBeat
iRhythm Technologies (NASDAQ:IRTC) Stock Price Down 7.7%What's Next? - MarketBeat
iRhythm stock remains a Buy at Needham, target increased on sales strength - Investing.com Canada
iRhythm Technologies Shares Fall 8% Following 2024, 2025 Outlooks - MarketWatch
iRhythm Technologies (NASDAQ:IRTC) Price Target Raised to $112.00 - MarketBeat
2025-01-13 | Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Connect | NDAQ:IRTC | Press Release - Stockhouse Publishing
iRhythm Technologies expects FY24 revenue slightly above guidance range - MSN
iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
iRhythm Surpasses 2024 Revenue Targets, Projects Strong 2025 Growth with Record Zio Monitor Adoption - StockTitan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach Out - AccessWire
2025-01-12 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach Out | NDAQ:IRTC | Press Release - Stockhouse Publishing
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Shareholders to Learn More About the Investigation - AccessWire
2025-01-09 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation | NDAQ:IRTC | Press Release - Stockhouse Publishing
iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire
Oppenheimer reiterates Outperform rating on iRhythm stock, highlighting strategic complementarity - Investing.com Australia
Vanguard Group Inc. Expands Stake in iRhythm Technologies Inc. - GuruFocus.com
iRhythm Technologies (NASDAQ:IRTC) Price Target Raised to $120.00 at Oppenheimer - MarketBeat
Oppenheimer reiterates Outperform rating on iRhythm stock, highlighting strategic complementarity By Investing.com - Investing.com South Africa
2025-01-08 | iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:IRTC | Press Release - Stockhouse Publishing
The Zacks Analyst Blog Highlights Tempus AI, iRhythm Technologies and SOPHiA GENETICS - Yahoo Finance
Tempus AI Stock Surges 23% in 6 Months: Should You Snap It Up Now? - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Connect - AccessWire
Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation - AccessWire
2025-01-06 | Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation | NDAQ:IRTC | Press Release - Stockhouse Publishing
Cardiac Monitoring Devices Market Size to Accumulate Around - GlobeNewswire
Wearable Patch Market Report 2025, with Profiles of Key Players Abbott, Medtronic, Dexcom, GlucoWatch, iRhythm Technologies, Insulet, Tactile Medical, VitalConnect, Qardio Myant & BioTelemetry - GlobeNewswire
Objective long/short (IRTC) Report - Stock Traders Daily
2025-01-05 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation | NDAQ:IRTC | Press Release - Stockhouse Publishing
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation - AccessWire
2025-01-03 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Reach Out | NDAQ:IRTC | Press Release - Stockhouse Publishing
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Reach Out - AccessWire
iRhythm Technologies Inc (IRTC) Shares Up 3.74% on Jan 1 - GuruFocus.com
iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - AccessWire
iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Stockholders to Learn More About the Investigation - AccessWire
IRhythm Technologies To Present At The 43rd Annual J.P. Morgan Healthcare Conference - Barchart
Wearable Heart Monitoring Devices Market Key Players Analysis - openPR
ECG Patch & Holter Monitor Market Report 2025- 2032| Industry Scope, Trends and Developments - WICZ
The Global Wearable Medical Devices Market to Grow Positively at a CAGR of 13.67% by 2030, DelveInsight - EIN News
iRhythm Technologies, Inc. (NASDAQ:IRTC) Receives $109.27 Average PT from Brokerages - MarketBeat
iRhythm price target raised to $111 from $85 at Truist - Yahoo Finance
iRhythm Technologies (NASDAQ:IRTC) Price Target Raised to $111.00 at Truist Financial - MarketBeat
State Street Corp Purchases 11,992 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
Barclays PLC Buys 53,498 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
Irhythm Technologies Inc (IRTC) 財務データ
収益
当期純利益
現金流量
EPS
Irhythm Technologies Inc (IRTC) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
TALWALKAR ABHIJIT Y | Director |
Nov 04 '24 |
Buy |
75.16 |
6,664 |
500,866 |
18,941 |
Blackford Quentin S. | President and CEO |
Nov 04 '24 |
Sale |
77.41 |
16,145 |
1,249,784 |
159,929 |
Bobzien Brice | Chief Financial Officer |
Aug 09 '24 |
Sale |
70.34 |
1,372 |
96,506 |
24,428 |
Patterson Chad | Chief Commercial Officer |
May 31 '24 |
Buy |
74.98 |
280 |
20,994 |
40,145 |
Patterson Chad | Chief Commercial Officer |
Aug 02 '24 |
Sale |
74.66 |
3,012 |
224,876 |
37,133 |
Smith Mervin | EVP Strategic Business Ops |
Aug 02 '24 |
Sale |
74.66 |
688 |
51,366 |
10,360 |
Turakhia Minang | EVP, CMO & CSO |
Jul 02 '24 |
Sale |
105.65 |
1,404 |
148,333 |
27,255 |
Rosenbaum Marc W. | Chief Accounting Officer |
Jun 03 '24 |
Sale |
88.91 |
510 |
45,344 |
8,174 |
Shrishrimal Sumi | EVP, Chief Risk Officer |
Jun 03 '24 |
Sale |
88.91 |
1,131 |
100,557 |
23,298 |
Day Mark J. | Chief Technology Officer |
Mar 04 '24 |
Sale |
111.14 |
3,248 |
360,983 |
61,164 |
大文字化:
|
ボリューム (24 時間):